Immune-Checkpoint Inhibitors as the First Line Treatment of Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

Background: This meta-analysis aimed to explore if immunotherapy or chemotherapy alone or in combination is a better first line treatment strategy for advanced non-small cell lung cancer (NSCLC) patients. Methods: Electronic databases including Google Scholar, PMC, PubMed, EMBASE, Scopus and the maj...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuqiao, Zhou, Yuan, Tang, Lu, Peng, Xiong, Jiang, Hong, Wang, Guo, Zhuang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856743/
https://www.ncbi.nlm.nih.gov/pubmed/31772659
http://dx.doi.org/10.7150/jca.34677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856743/
https://www.ncbi.nlm.nih.gov/pubmed/31772659
http://dx.doi.org/10.7150/jca.34677

Ejemplares similares